logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
T

Tom Stargardt

Free University of Bozen-Bolzano

32H-index
173Paper Count
4.3KCitation Count
Published Papers 70
Publication Date
logo
Strategies for sustainable lung cancer screening: a multi-faceted perspective to long-term surveillance in SOLACE
errInsights into Imaging
IF4.5
err2026-04-07
err0
errOAAI
errEmily Nischwitz; Roberta Eufrasia Ledda; Tom Stargardt; Carsten Wältner; Katarzyna Sejbuk-Rozbicka; Joanna Bidzinska; Joanna Moes-Sosnowska; Joanna Chorostowska-Wynimko; Mathis Konrad; Elizabeth Tong; Małgorzata Gałazka-Sobotka; Edyta Szurowska; Dominik R. Dziurda; Hans-Ulrich Kauczor; Viktoria Palm
errShare
errSave
The economic burden of loiasis: A comprehensive cost-of-illness analysis of regionally representative, individual-level data from rural Gabon
errPLoS One
IF2.6
err2026-02-23
err0
PREAI
errMbavu, Cedric Isaac; Perlik, Kerstin; Stargardt, Tom; Agnandji, Selidji Todagbe; Adegnika, Olouyomi Scherif; Zoleko-Manego, Rella; Ramharter, Michael; Priebe, Jan
errShare
errSave
Demographic and health impacts of women’s bodily autonomy: switching prescription requirements for emergency contraceptives
errThe European Journal of Health Economics
IF0
err2025-11-20
err0
errOAAI
errFabian Grünwald; Tom Stargardt
errShare
errSave
Cost-utility analysis of 177Lu-PSMA-617 radioligand therapy in second-line and third-line treatment for metastatic castration-resistant prostate cancer (mCRPC) in Germany
errEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
IF7.6
err2025-05-08
err0
errOAAI
errBrinkmann, Carolin; Baum, Richard P.; Stargardt, Tom
errShare
errSave
From Health to Well-Being: Toward a Monetary Valuation of a Well-Being-Adjusted Life-Year
errVALUE IN HEALTH
IF6
err2024-07-01
err2
PREAI
errBrinkmann, Carolin; Stargardt, Tom; Brouwer, Werner B. F.
errShare
errSave
Inflammatory bowel disease (IBD) patients with impaired quality of life on biologic therapy benefit from the support of an IBD nurse specialist: Results of a randomised controlled trial in Germany (IBDBIO-ASSIST study)
errALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
err2024-03-01
err1
errOAAI
errBokemeyer, Bernd; Plachta-Danielzik, Sandra; Steiner, Isa Maria; Pohlschneider, Daniela; Urzica, Eugen; Hartmann, Petra; Zemke, Jennifer; Tappe, Ulrich; Schreiber, Stefan; Steinkat, Nadine; Langbrandtner, Jana; Hueppe, Angelika; Stargardt, Tom
errShare
errSave
Authors' Reply to Gandjour: 10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?
errAPPLIED HEALTH ECONOMICS AND HEALTH POLICY
IF3.3
err2023-12-02
err0
errOAAI
errBuessgen, Melanie; Stargardt, Tom
errShare
errSave
Socioeconomic Disparities In Mortality And Health Care Use During The COVID-19 Pandemic: Evidence From Germany
errHEALTH AFFAIRS
IF8.1
err2023-12-01
err0
errOAAI
errBayindir, Esra Eren; Messerle, Robert; Stargardt, Tom; Schreyoegg, Jonas
errShare
errSave
Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic (Jul, 10.1007/s10198-023-01604-8, 2023)
errEUROPEAN JOURNAL OF HEALTH ECONOMICS
IF3
err2023-10-21
err0
errOAAI
errHimmler, Sebastian; van Exel, Job; Brouwer, Werner; Neumann-Boehme, Sebastian; Sabat, Iryna; Schreyoegg, Jonas; Stargardt, Tom; Barros, Pedro Pita; Torbica, Aleksandra
errShare
errSave
Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic
errEUROPEAN JOURNAL OF HEALTH ECONOMICS
IF3
err2023-07-06
err5
errOAAI
errHimmler, Sebastian; van Exel, Job; Brouwer, Werner; Neuman-Boehme, Sebastian; Sabat, Iryna; Schreyoegg, Jonas; Stargardt, Tom; Barros, Pedro Pita; Torbica, Aleksandra
errShare
errSave
Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel disease
errEUROPEAN JOURNAL OF HEALTH ECONOMICS
IF3
err2023-06-27
err8
errOAAI
errSteiner, Isa Maria; Bokemeyer, Bernd; Stargardt, Tom
errShare
errSave
Does health technology assessment compromise access to pharmaceuticals?
errEUROPEAN JOURNAL OF HEALTH ECONOMICS
IF3
err2023-06-19
err1
errOAAI
errBuessgen, Melanie; Stargardt, Tom
errShare
errSave
Market diffusion of biosimilars in off-patent biologic drug markets across Europe
errHEALTH POLICY
IF3.4
err2023-06-01
err4
PREAI
errBoehm, Anna-Katharina; Steiner, Isa Maria; Stargardt, Tom
errShare
errSave
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?
errAPPLIED HEALTH ECONOMICS AND HEALTH POLICY
IF3.3
err2023-05-30
err2
errOAAI
errBuessgen, Melanie; Stargardt, Tom
errShare
errSave
Does prospective payment influence quality of care? A systematic review of the literature
errSOCIAL SCIENCE & MEDICINE
IF5
err2023-04-01
err2
PREAI
errPott, Clara; Stargardt, Tom; Frey, Simon
errShare
errSave
Health-related quality of life in seven European countries throughout the course of the COVID-19 pandemic: evidence from the European COvid Survey (ECOS)
errQUALITY OF LIFE RESEARCH
IF2.7
err2023-02-05
err15
errOAAI
errKoenig, Hans-Helmut; Neumann-Boehme, Sebastian; Sabat, Iryna; Schreyoegg, Jonas; Torbica, Aleksandra; van Exel, Job; Barros, Pedro Pita; Stargardt, Tom; Hajek, Andre
errShare
errSave
Patient expectations do matter-Experimental evidence on antibiotic prescribing decisions among hospital-based physicians
errHEALTH POLICY
IF3.4
err2023-02-01
err7
errOAAI
errWang, Sophie Y.; Cantarelli, Paola; Groene, Oliver; Stargardt, Tom; Belle, Nicola
errShare
errSave
Cost-utility analysis of early versus delayed endovascular intervention in critical limb-threatening ischemia patients with rest pain
errJOURNAL OF VASCULAR SURGERY
IF3.6
err2023-01-01
err4
errOAAI
errVadia, Rucha; Malyar, Nasser; Stargardt, Tom
errShare
errSave
Depression and anxiety in later COVID-19 waves across Europe: New evidence from the European COvid Survey (ECOS)
errPSYCHIATRY RESEARCH
IF3.9
err2022-11-01
err17
errOAAI
errHajek, Andre; Neumann-Boehme, Sebastian; Sabat, Iryna; Torbica, Aleksandra; Schreyoegg, Jonas; Barros, Pedro Pita; Stargardt, Tom; Koenig, Hans-Helmut
errShare
errSave
Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients
errAPPLIED HEALTH ECONOMICS AND HEALTH POLICY
IF3.3
err2022-10-31
err2
errOAAI
errBoehm, Anna-Katharina; Schneider, Udo; Stargardt, Tom
errShare
errSave

Research Directions

The data has not been retrieved yet.
Co-authors
Cooperation Journals
S
Stefan Schreiber
H-index: 192 · Papers: 1.9K
T
Tobias Welte
H-index: 127 · Papers: 2.0K
E
Emilio Bouza
H-index: 99 · Papers: 1.2K
K
Ken Herrmann
H-index: 94 · Papers: 976
A
Andreas K. Buck
H-index: 85 · Papers: 662
View more